For: | Shi YX, Huang CJ, Yang ZG. Impact of hepatitis B virus infection on hepatic metabolic signaling pathway. World J Gastroenterol 2016; 22(36): 8161-8167 [PMID: PMC5037084 DOI: 10.3748/wjg.v22.i36.8161] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i36/8161.htm |
Number | Citing Articles |
1 |
Isha Sengupta, Atanu Mondal, Amrita Sengupta, Chandrima Das. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1639 doi: 10.1007/978-981-16-5422-0_83
|
2 |
Noe Rico Montanari, Ricardo Ramírez, Abhishek Aggarwal, Nick van Buuren, Michael Doukas, Christina Moon, Scott Turner, Lauri Diehl, Li Li, Jose D. Debes, Becket Feierbach, Andre Boonstra. Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection. Journal of Hepatology 2022; 77(2): 332 doi: 10.1016/j.jhep.2022.02.016
|
3 |
Wenning Lan, Yang Wang, Zixiong Zhou, Xia Sun, Yun Zhang, Fangrong Zhang. Metabolic Regulation of Hepatitis B Virus Infection in HBV-Transgenic Mice. Metabolites 2022; 12(4): 287 doi: 10.3390/metabo12040287
|
4 |
Jingru Song, Yanping Huang, Lu Liu, Dengcheng Hui, Zheng Wang, Dong Xie, Yulang Jiang, Hongyan Cao, Yancheng Dai, Guan Ye, Shibing Su, Mingmei Zhou, Qin Zhang, Mingyu Sun. Integrated metabolomics and network pharmacology to explore the clinical efficacy and mechanism of Yinchenhao decoction combined with nucleoside analogues on chronic hepatitis B. Journal of Pharmaceutical and Biomedical Analysis 2025; 253: 116513 doi: 10.1016/j.jpba.2024.116513
|
5 |
Han-Na Kim, Hae Suk Cheong, Bomi Kim, Won Sohn, Yong Kyun Cho, Min-Jung Kwon, Juhee Kim, Youngmi Song, Eun-Jeong Joo. Human gut microbiota from hepatitis B virus-infected individuals is associated with reduced triglyceride level in mice: faecal transplantation study. Microbes and Infection 2024; 26(3): 105281 doi: 10.1016/j.micinf.2023.105281
|
6 |
Lili Zhou, Shaohuai Xia, Yaoyao Liu, Qiang Ji, Lifeng Li, Xuan Gao, Xiaodi Guo, Xin Yi, Feng Chen. A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01780-9
|
7 |
Wanyu Deng, Mengji Lu. The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication. Virologica Sinica 2016; 31(6): 472 doi: 10.1007/s12250-016-3924-0
|
8 |
Zhen Xun, Jin-Piao Lin, Can Liu, Jin-Lan Huang, Ye Shen, Si-Yi Xu, Wen-Nan Wu, Qi-Shui Ou. Association of Serum Total Cholesterol with Pegylated Interferon-α Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Antiviral Therapy 2019; 24(2): 85 doi: 10.3851/IMP3282
|
9 |
Annika Jasmin Walter, Maarten A. van de Klundert, Stephanie Jung. Many Ways to Communicate—Crosstalk between the HBV-Infected Cell and Its Environment. Pathogens 2022; 12(1): 29 doi: 10.3390/pathogens12010029
|
10 |
Anika Dutta, Neelam Sharma-Walia. Curbing Lipids: Impacts ON Cancer and Viral Infection. International Journal of Molecular Sciences 2019; 20(3): 644 doi: 10.3390/ijms20030644
|
11 |
Isha Sengupta, Atanu Mondal, Amrita Sengupta, Chandrima Das. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1 doi: 10.1007/978-981-16-1247-3_83-1
|
12 |
Monika Mani, Shanthi Vijayaraghavan, Gopalsamy Sarangan, Abhinaya Raguramachandran, Padma Srikanth. Hepatitis B virus genotype D in T2DM: A report from a tertiary care centre, Chennai. Obesity Medicine 2020; 17: 100160 doi: 10.1016/j.obmed.2019.100160
|
13 |
Dibya L. Praharaj, Anil C. Anand. Nutrition in Viral Hepatitis. Current Hepatology Reports 2023; 22(1): 9 doi: 10.1007/s11901-023-00596-6
|
14 |
Yongdong Niu, Liming Chen, Manpeng Wu, Weiyi Huang, Xuejun Wu, Danmei Huang, Yangmin Xie, Ganggang Shi. Partial abrogation of FXR-KNG1 signaling by carboxyl-terminal truncated HBx-C30 in hepatitis B virus-associated hepatocellular carcinoma. Virus Research 2021; 293: 198264 doi: 10.1016/j.virusres.2020.198264
|
15 |
Evanthia Tourkochristou, Stelios F. Assimakopoulos, Konstantinos Thomopoulos, Markos Marangos, Christos Triantos. NAFLD and HBV interplay - related mechanisms underlying liver disease progression. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.965548
|
16 |
Nima Sarfaraz, Srinivas Somarowthu, Michael J. Bouchard. The interplay of long noncoding RNAs and hepatitis B virus. Journal of Medical Virology 2023; 95(1) doi: 10.1002/jmv.28058
|
17 |
Shuzhen Wang, Jie Liu, Qiaolian Wang, Jianguo Du, Beibei Wang. The CDKN2A polymorphisms and the susceptibility of HBV‐related gestational diabetes mellitus. Journal of Clinical Laboratory Analysis 2018; 32(6) doi: 10.1002/jcla.22423
|
18 |
Kenneth Hodge, Jiradej Makjaroen, Jonathan Robinson, Sakda Khoomrung, Trairak Pisitkun. Deep Proteomic Deconvolution of Interferons and HBV Transfection Effects on a Hepatoblastoma Cell Line. ACS Omega 2020; 5(27): 16796 doi: 10.1021/acsomega.0c01865
|
19 |
Chenxuan Li, En-di Zhang, Youzhi Ye, Zhongyun Xiao, Hanfei Huang, Zhong Zeng. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64907-7
|
20 |
Amy D. Proal, Michael B. VanElzakker. Pathogens Hijack Host Cell Metabolism: Intracellular Infection as a Driver of the Warburg Effect in Cancer and Other Chronic Inflammatory Conditions. Immunometabolism 2021; 3(1) doi: 10.20900/immunometab20210003
|
21 |
Ming-Whei Yu, Chih-Lin Lin, Chun-Jen Liu, Shu-Han Yang, Yu-Lin Tseng, Chih-Feng Wu. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study. Gastroenterology 2017; 153(4): 1006 doi: 10.1053/j.gastro.2017.07.001
|
22 |
Yingying Zhao, Huichun Xing, Xiaomei Wang, Weini Ou, Hong Zhao, Ben Li, Yue Li, Ying Duan, Liwei Zhuang, Wei Li, Danying Cheng, Min Quan, Yu Zhang, Shibo Ji. Management of Diabetes Mellitus in Patients with Chronic Liver Diseases. Journal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/6430486
|
23 |
Na Liu, Feng Shi, Lifang Yang, Weihua Liao, Ya Cao. Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188724 doi: 10.1016/j.bbcan.2022.188724
|
24 |
Merve Sefa Sayar, Dilek Bulut, Ali Acar. Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection. Arab Journal of Gastroenterology 2023; 24(1): 11 doi: 10.1016/j.ajg.2022.05.002
|
25 |
Hongxia Fan, Qiaoge Zhang, Xiaopei Zhao, Ping Lv, Min Liu, Hua Tang. Transcriptomic profiling of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma. Oncotarget 2017; 8(39): 65421 doi: 10.18632/oncotarget.18897
|
26 |
Ezequiel Monferrer, Sabina Sanegre, Isaac Vieco-Martí, Amparo López-Carrasco, Fernando Fariñas, Antonio Villatoro, Sergio Abanades, Santos Mañes, Luis de la Cruz-Merino, Rosa Noguera, Tomás Álvaro Naranjo. Immunometabolism Modulation in Therapy. Biomedicines 2021; 9(7): 798 doi: 10.3390/biomedicines9070798
|
27 |
Qingqin Hao, Zheng Wang, Qinghui Wang, Wei Xia, Hong Cao, Zhonghua Lu, Huizhong Qian. Differential expression profile of long noncoding RNAs in chronic HBV infection: New insights into pathogenesis. Journal of Medical Virology 2020; 92(12): 3390 doi: 10.1002/jmv.25851
|
28 |
Jiaxuan Zhang, Ning Ling, Yu Lei, Mingli Peng, Peng Hu, Min Chen. Multifaceted Interaction Between Hepatitis B Virus Infection and Lipid Metabolism in Hepatocytes: A Potential Target of Antiviral Therapy for Chronic Hepatitis B. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.636897
|
29 |
Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis. Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt – results from the GUARD study. Curr Med Res Opin 2017;33:797-801. Current Medical Research and Opinion 2017; 33(12): 2261 doi: 10.1080/03007995.2017.1333955
|
30 |
Shivani K. Thaker, James Ch’ng, Heather R. Christofk. Viral hijacking of cellular metabolism. BMC Biology 2019; 17(1) doi: 10.1186/s12915-019-0678-9
|
31 |
Wenqiang Wei, Wanting Kong. Identification of key genes and signaling pathways during Sendai virus infection in vitro. Brazilian Journal of Microbiology 2019; 50(1): 13 doi: 10.1007/s42770-018-0021-6
|
32 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
33 |
Jesse JR Masson, Hugh WW Billings, Clovis S Palmer. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities. Antiviral Chemistry and Chemotherapy 2017; 25(2): 53 doi: 10.1177/2040206617701372
|
34 |
Changbo Qu, Shaoshi Zhang, Wenshi Wang, Meng Li, Yijin Wang, Marieke van der Heijde-Mulder, Ehsan Shokrollahi, Mohamad S. Hakim, Nicolaas J. H. Raat, Maikel P. Peppelenbosch, Qiuwei Pan. Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target. The FASEB Journal 2019; 33(1): 1008 doi: 10.1096/fj.201800620R
|
35 |
Changbo Qu, Shaoshi Zhang, Yang Li, Yijin Wang, Maikel P. Peppelenbosch, Qiuwei Pan. Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections. Reviews in Medical Virology 2019; 29(5) doi: 10.1002/rmv.2075
|
36 |
Hangle Wang, Jun Zhang. The glucose metabolic reprogramming in hepatitis B virus infection and hepatitis B virus associated diseases. Journal of Gastroenterology and Hepatology 2023; 38(11): 1886 doi: 10.1111/jgh.16340
|
37 |
Mei-Ling Cheng, Kun-Yi Chien, Chien-Hsueh Lai, Guan-Jie Li, Jui-Fen Lin, Hung-Yao Ho. Metabolic Reprogramming of Host Cells in Response to Enteroviral Infection. Cells 2020; 9(2): 473 doi: 10.3390/cells9020473
|
38 |
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
|
39 |
Nadine Ahmed, Noreen Ahmed, Roxana Filip, John Paul Pezacki. Nuclear Receptors. 2021; : 315 doi: 10.1007/978-3-030-78315-0_13
|
40 |
Ziqiang Xia, Juzeng Zheng, Liang Zheng, Endian Zheng, Zhuolin Zou, Xiong Sheng, Jinming Wu. Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01582-x
|
41 |
Caorui Lin, Qishui Ou. Emerging role of mitochondria in response to HBV infection. Journal of Clinical Laboratory Analysis 2022; 36(10) doi: 10.1002/jcla.24704
|
42 |
Benjamin Y. Winer, Jenna M. Gaska, Gabriel Lipkowitz, Yaron Bram, Amit Parekh, Lance Parsons, Robert Leach, Rohit Jindal, Cheul H. Cho, Anil Shrirao, Eric Novik, Robert E. Schwartz, Alexander Ploss. Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro‐scalable Hepatic Co‐culture System. Hepatology 2020; 71(1): 14 doi: 10.1002/hep.30815
|
43 |
Alexis Jose-Abrego, Sonia Roman, Saul Laguna-Meraz, Arturo Panduro. Host and HBV Interactions and Their Potential Impact on Clinical Outcomes. Pathogens 2023; 12(9): 1146 doi: 10.3390/pathogens12091146
|
44 |
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Gure, Secil Demirkol-Canli. Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 2023; 12(2): 188 doi: 10.3390/biology12020188
|
45 |
Noe Rico Montanari, Ricardo Ramirez, Nick Van Buuren, Thierry P P van den Bosch, Michail Doukas, Jose D Debes, Becket Feierbach, Andre Boonstra. Transcriptomic Analysis of Livers of Inactive Carriers of Hepatitis B Virus With Distinct Expression of Hepatitis B Surface Antigen. The Journal of Infectious Diseases 2022; 225(6): 1081 doi: 10.1093/infdis/jiab381
|
46 |
Fangying Li, Xiaozhe Fu, Xia Luo, Qiang Lin, Hongru Liang, Yinjie Niu, Lihui Liu, Ningqiu Li. Role of asparagine biosynthesis pathway in Siniperca chuatsi rhabdovirus proliferation. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1165491
|
47 |
Eun-Jeong Joo, Hae Suk Cheong, Min-Jung Kwon, Won Sohn, Han-Na Kim, Yong Kyun Cho. Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00461-1
|
48 |
José Arquimídes Godoy-Lugo, Melissa M. Miranda-Cruz, Jesús Alfredo Rosas-Rodríguez, Norma Patricia Adan-Bante, Ramona Icedo-García, José Guadalupe Soñanez-Organis. Hypoxia inducible factor −1 regulates WSSV-induced glycolytic genes in the white shrimp Litopenaeus vannamei. Fish & Shellfish Immunology 2019; 92: 165 doi: 10.1016/j.fsi.2019.05.040
|
49 |
Eun‐Jeong Joo, Yoosoo Chang, Joon‐Sup Yeom, Yong Kyun Cho, Seungho Ryu. Chronic hepatitis B virus infection and risk of dyslipidaemia: A cohort study. Journal of Viral Hepatitis 2019; 26(1): 162 doi: 10.1111/jvh.13014
|
50 |
Syed Shahariar Bappy, Md. Muzammal Haque Asim, Mohammad Mainul Ahasan, Asif Ahsan, Sorna Sultana, Roksana Khanam, Abu Zaffar Shibly, Yearul Kabir. Virus‐induced host cell metabolic alteration. Reviews in Medical Virology 2024; 34(1) doi: 10.1002/rmv.2505
|
51 |
Duo Zuo, Jiawei Xiao, Haohua An, Yongzi Chen, Jianhua Li, Xiaohui Yang, Xia Wang, Li Ren. Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic Potential of ANGPTL6 for HBV-Related Early-Stage Hepatocellular Carcinoma. Biomolecules 2022; 12(11): 1700 doi: 10.3390/biom12111700
|
52 |
Baocun Li, Yang Wang, Fang Shen, Min Wu, Yaming Li, Zhong Fang, Jianyu Ye, Li Wang, Lu Gao, Zhenghong Yuan, Jieliang Chen. Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen. Antimicrobial Agents and Chemotherapy 2018; 62(12) doi: 10.1128/AAC.00465-18
|
53 |
Pushpak Bhattacharjee, Die Wang, Dovile Anderson, Joshua N Buckler, Eveline de Geus, Feng Yan, Galina Polekhina, Ralf Schittenhelm, Darren J Creek, Lawrence D Harris, Anthony J Sadler. The immune response to RNA suppresses nucleic acid synthesis by limiting ribose 5-phosphate. The EMBO Journal 2024; 43(13): 2636 doi: 10.1038/s44318-024-00100-w
|
54 |
Shi-Qin Li, Yue Shen, Jun Zhang, Cheng-Zhao Weng, Sheng-Di Wu, Wei Jiang. Immune modulation of gut microbiota and its metabolites in chronic hepatitis B. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1285556
|
55 |
Huichun Shi, Siyuan Liu, Zhimi Tan, Lin Yin, Liyan Zeng, Tiefu Liu, Shuye Zhang, Lijun Zhang. Proteomic and metabonomic analysis uncovering Enterovirus A71 reprogramming host cell metabolic pathway. PROTEOMICS 2023; 23(2) doi: 10.1002/pmic.202200362
|
56 |
Ting Cai, Tingting Yue, Ming Xu, Pan Zhang, Yue Wang, Qi Liu, Jie Huang, Ting Shen, Qiang Yin, Zhifeng Sheng, Yang Xiao, Tuo Deng, Min Zhang, Erik De Clercq, Chi Zhang, Guangdi Li. Poor glycemic control in type‐2 diabetic patients infected with hepatitis B: A retrospective propensity‐matched study. Journal of Medical Virology 2023; 95(3) doi: 10.1002/jmv.28635
|